Can the cardiomyocyte cell cycle be reprogrammed?
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 42 (4) , 706-721
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarctionProceedings of the National Academy of Sciences, 2006
- Generation of a conditional null allele of jumonjiGenesis, 2006
- Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2‐dependent pathwayThe EMBO Journal, 2006
- Stem cell niches in the adult mouse heartProceedings of the National Academy of Sciences, 2006
- Combined Loss of Cdk2 and Cdk4 Results in Embryonic Lethality and Rb HypophosphorylationDevelopmental Cell, 2006
- Down-regulation of p27 Promotes Cell Proliferation of Rat Neonatal Cardiomyocytes Induced by Nuclear Expression of Cyclin D1 and CDK4Journal of Biological Chemistry, 2004
- Heart Regeneration in ZebrafishScience, 2002
- Jumonji Is a Nuclear Protein That Participates in the Negative Regulation of Cell GrowthBiochemical and Biophysical Research Communications, 2000
- Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesisNature, 1992
- Effects of an Rb mutation in the mouseNature, 1992